¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"principal value of strain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • inbred strain
    ¼ø°è, ±ÙÄ£±³°è
  • indicator strain
    ±âÁؼ¼±ÕÁÖ, Ç¥Áؼ¼±ÕÁÖ
  • lysogenic strain
    ¿ë¿øÁÖ
  • muscular strain
    1. ±Ù(À°)°úµµ±äÀå 2. ±ÙÀ°¿°ÁÂ
  • nosocomial strain
    º´¿ø³»±ÕÁÖ
  • permanent strain
    ¿µ±¸º¯Çü
  • rough strain
    °ÅÄ£Áý¶ô±ÕÁÖ
  • reference strain
    Ç¥ÁرÕÁÖ, Ç¥ÁØÁÖ
  • right ventricular strain
    ¿ì½É½Ç±äÀå, ¿À¸¥½É½Ç±äÀå
  • strain
    1. ±ÕÁÖ, ¼¼Æ÷ÁÖ, ÁÖ 2. ±äÀå, °úµµ±äÀå 3. ¿°Á 4. º¯Çü, º¯Çü·ü
  • strain gauge
    ¾Ð·ÂÀü´Þ°è
  • strain specificity
    ÁÖÆ¯À̼º
  • sensitive strain
    ¹Î°¨±ÕÁÖ
  • smooth strain
    ¸Å²öÁý¶ô±ÕÁÖ, ÆòȰÁý¶ô±ÕÁÖ
  • wild type strain
    ¾ß»ýÁÖ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • value system
    °¡Ä¡Ã¼°è
  • threshold value
    ¹®Åΰª, ¿ªÄ¡
  • typical value
    ´ëǥġ
  • value
    °ª, °¡Ä¡, Ä¡
  • bacterial strain
    ±ÕÁÖ
  • cell strain
    ¼¼Æ÷ÁÖ
  • congeneic mouse strain
    ±Ø¼ÒÀÌÀ¯ÀüÀÚÇü¸¶¿ì½ºÁÖ
  • dependent strain
    ÀÇÁ¸ÁÖ
  • diploid cell strain
    À̹èü¼¼Æ÷ÁÖ
  • stress strain diagram
    ÀÀ·ÂÀǷ»óŵµ
  • epidemic strain
    À¯Çà±ÕÁÖ
  • eye strain
    ´«ÇÇ·Î
  • strain gauge
    ¾Ð·ÂÀü´Þ°è
  • heterologous strain
    ÀÌÁ¾ÁÖ
  • hospital strain
    º´¿ø°¨¿°ÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • inner principal layer
    ³»ÇÙÃþ.
  • principal axis
    ÁÖÃà(ñ«õî).
  • principal cell
    ÁÖ¼¼Æ÷(ñ«á¬øà).
  • principal cell
    À¸¶ä¼¼Æ÷
  • principal cell
    ÁÖ¼¼Æ÷(ñ«á¬øà).
  • principal component
    ÁÖ¼ººÐ(ñ«à÷ÝÂ).
  • principal fiber
    À¸¶ä¼¶À¯
  • principal focus
    ÁÖÃÊÁ¡(ñ«õ¥ïÇ).
  • principal meridian
    ÁÖ°æ¼±
  • principal nucleolus
    À¸¶äÇÙ¼Òü
  • principal outer membrane protein (POMP)
    ÁÖ¿ä¿Ü¸·´Ü¹éÁú
  • principal part
    À¸¶äºÎºÐ
  • principal piece
    ÁֵȺκÐ
  • principal piece
    À¸¶äºÎºÐ
  • principal plane
    ÁÖ¸é(ñ«Øü).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dependent strain
    ÀÇÁ¸ÁÖ(Ëô̡̡).
  • diploid cell strain
    À̹èü ¼¼Æ÷ÁÖ
  • elastic strain energy
    ź¼º º¯Çü ¿¡³ÊÁö.
  • elastic strain energy
    ź¼ºº¯Çü¿¡³ÊÁö.
  • epidemic strain
    À¯Çà±ÕÁÖ.
  • eye strain
    ´«ÇÇ·Î, ¾ÈÁ¤ÇÇ·Î.
  • heterologous strain
    ÀÌÁ¾ÁÖ(ì¶ðúñ»).
  • hospital strain
    º´¿øÁÖ(Ü»êÂñ»).
  • inbred strain
    ¼ø°èµ¿¹°, ±Ù±³¹èµ¿¹°
  • indicator strain
    Áö½ÃÁÖ(ò¦ãÆñ»).
  • indicator strain
    Áö½ÃÁÖ(ò¦ãÆñ»).
  • left heart strain
    Á½ɱäÀå(ñ§ãýÑÌíå).
  • left ventricular strain
    ÁÂ(½É)½Ç±äÀå(ñ§ãýãøÑÌíå).
  • lysogenic strain
    ¿ë¿øÁÖ
  • lysogenic strain
    ¿ë¿øÁÖ(éÁê«ñ»).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • D value
    D °ª (ÔÒ) decimal reduction time
  • ester value
    ¿¡½ºÅÍ °ª
  • F value
    F °ª
  • g value
    g °ª
  • G value
    G °ª
  • half-value dose
    ¹Ý(Úâ)°ª ¼±·®(àÊÕá)
  • half-value layer
    ¹Ý°¨Ãþ(ÚâÊõöµ)
  • hydroxyl value
    ÇÏÀ̵å·Ï½Ç°ª
  • Kirschner value
    Ű½´³Ê°ª
  • probability value
    È®·ü(ü¬×Ë) °ª
  • protein value
    ´Ü¹éÁú(Ó±ÛÜòõ)°ª
  • p value
    p °ª
  • p50 value
    p50 °ª
  • Q value
    Q
  • recombination value
    ÀçÁ¶ÇÕ(î¢ðÚùê) °ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CFW Carworth farm [mouse], Webster strain
col collection; colicin; collagen; colony; colored; column; strain [Lat. cola]
CVS cardiovascular surgery; cardiovascular system; challenge virus strain; chorionic villi sampling; cle...
HDCS human diploid cell strain
LBS low back syndrome; lumbar back strain
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
EBV Estimated breeding value
LVS Live Vaccine Strain
MV Maturation Value
MHS Milan Hypertensive Strain
MNS Milan Normotensive Strain
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
strain A tearing injury to muscle. Usually causes some degree of bleeding within the muscle tissue (haematoma).
(27 Sep 1997)
strain birefringence <chemistry> Optical property of a material in which the refractive index is different for light polarized in one plane compared to the orthogonal plane.
May arise from molecular organisation of the material (form birefringence.), alignment of molecules due to tension (stress birefringence.) or alignment of rod like particles in flow (flow birefringence).
With crossed Nicoll prisms a birefringent material appears bright against a dark background.
(19 Jan 1998)
strain development Improving the genetics of an organism so that it carries out a biotechnological process more effectively.
(14 Nov 1997)
strain fracture The tearing off, by a sudden force, of a piece of bone attached to a tendon, ligament, or capsule; the force may be exogenous or endogenous.
(05 Mar 2000)
strain gauge A device, employing the Wheatstone bridge principle, used for accurate measurement of forces such as strain, stress, or pressure.
(05 Mar 2000)
stress-strain curve A curve showing the ratio of deformation to load during the testing of a material in tension.
(05 Mar 2000)
inbred strain Any strain of animal or plant obtained by a breeding strategy that tends to lead to homozygosity. Such breeding strategies include brother sister mating and back crossing of offspring with parents.
See: congenic.
(18 Nov 1997)
isogenic strain A strain of animals inbred for many generations and with high probability homozygous for certain specified genes.
(05 Mar 2000)
type strain The nomenclatural type of a species or subspecies.
(05 Mar 2000)
Flury strain rabies virus <organism, virology> Species of the Rhabdoviridae that causes rabies in humans. The virus infects the cells in the brain, causing a fatal encephalomyelitis. It is found all over the world, but strict quarantine regulations have excluded it from Britain and Australia. The virus infects a number of domestic and wild mammals, whose saliva is infective. Some bats and small mammals can carry the virus without showing any symptoms of disease.
(18 Nov 1997)
Flury strain vaccine An inactivated virus vaccine, used for preexposure immunization to persons at high risk of exposure, e.g., veterinarians, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. The official preparation is human diploid cell vaccine produced from rabies virus grown in cultures of human diploid embryo lung cells and inactivated with propriolactone. It has a much lower incidence of adverse reactions than the previously used duck embryo vaccine.
(12 Dec 1998)
lysogenic strain A strain of bacterium that is infected with a temporate bacteriophage.
See: lysogeny.
(05 Mar 2000)
acetyl value The milligrams of KOH required to neutralise the acetic acid produced by the hydrolysis of 1 g of acetylated fat; a measure of the hydroxy acids present in glycerides; notably high in castor oil.
(05 Mar 2000)
beta, or beta-value <radiobiology> Ratio of plasma kinetic pressure to magnetic-field pressure, proportional to the ratio of plasma kinetic energy density to magnetic field energy density. Beta is usually measured relative to the total, local field (loosely called beta toroidal), but sometimes the plasma pressure relative to only the poloidal component of the field (beta poloidal) or relative to some external field (like the maximum field at the magnetic coils) is more useful. There is also a normalised beta (beta_N) of interest when discussing the beta limit. (lots of help from Art Carlson with the above.) Because the cost of a reactor is strongly influenced by the strength of the magnetic field that must be provided, beta values are directly related to the economics of fusion power production. Beta is usually expressed as a percentage, with 5% generally believed to be the minimum value required for an economical fusion reactor.
See: pressure, kinetic pressure, magnetic pressure, second stability.
(09 Oct 1997)
biological value <nutrition> The nutritional value of a protein, usually measured in comparison to the nutritional value of egg protein, which is the highest possible (BV=0.9 - 1.00).
(21 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • expected value
    (Åë°è)±â´ë°ª
  • face value
    ¾×¸é °¡°Ý;±Ç¸é¾×;¾×¸é(Ç¥¸é)»óÀÇ °¡Ä¡(ÀǹÌ)
  • food value
    (½ÄǰÀÇ) ¿µ¾ç°¡
  • market value
    ½ÃÀå °¡°Ý
  • market value GNP
    ½Ã°¡ ±âÁØÀÇ ±¹¹Î ÃÑ»ý»ê 
  • news value
    º¸µµ °¡Ä¡
  • nominal value
    (Áõ±ÇµûÀ§ÀÇ) ¾×¸é°¡°Ý
  • nuisance value
    °ñÅÁ¸ÔÀÌ´Â °¡Ä¡(È¿°ú);(¼Ò±Ô¸ð Æø°ÝµîÀÇ)¹æÇØ È¿°ú 9
  • par value
    ¾×¸é °¡°Ý
  • present value
    Çö°¡(¿¹ÄÁ´ë ȰÀεǴ ¾îÀ½ÀÇ ÇöÀçÀÇ °¡Ä¡)
  • ratable value
    (Áö¹æ¼¼ÀÇ)°ú¼¼ Æò°¡¾×
  • scarcity value
    Èñ¼Ò °¡Ä¡
  • value
    °¡Ä¡;À¯¿ë¼º;Æò°¡;°ª¾îÄ¡;¾×¸é±Ý¾×;´ë°¡(¹°);»ó´ç °¡°Ý(¹°);ÀÇÀÇ;°ª;(»çȸÀû)°¡Ä¡(±âÁØ);À½ÀÇ Àå´Ü;¸í¾ÏÀÇ (Á¤)µµ
  • value
    Æò°¡(Á¸Áß)ÇÏ´Ù;~ oneself »Ë³»´Ù(for,on)
  • value judg(e)ment
    °¡Ä¡ÆÇ´Ü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á